Obesity, Type 2 Diabetes Mellitus
Conditions
Keywords
type 2 diabetes mellitus in obese, insulin secretion, innate immunity, monocyte programming, remission of type 2 diabetes, weight loss
Brief summary
People with a body mass index above 28 kg/m² and an onset of type 2 diabetes within the last 4 years had a remission (HbA1c \<6.5% without medication) of diabetes in over 80% upon weight loss of 15 kg. Longer duration of diabetes reduced the chance of remission. The investigators will test whether there is a difference in remission upon weight loss of 15 kg using formula low calorie diets between subjects with a diabetes duration of \<4 years vs. \>8 years and oral treatment as primary end points. The immune metabolic programming of circulating monocytes will be investigated in detail regarding trained innate immunity and the endocrine responses will be determined using meal challenge tests.
Detailed description
A remission of type 2 diabetes can be achieved in over 80% of people with a diagnosis within the last 4 years and overweight or obesity by weight loss of 15 kg. The mechanisms involve an improvement of insulin sensitivity and thereby insulin requirements and a regain of the function of insulin secreting beta cells. Longer duration of type 2 diabetes appears to impair the capacity of beta cell to regenerate. At present it is not possibe to predict success of the weight loss at an early time point. The investigators therefore aim to identify early markers of responders. It is unclear how the weight loss induces the remission in responders. Immune cells are known to contribute to insulin resistance by regulating adipose tissue function and hepatic and skeletal muscle metabolism by releasing cytokines. The inborn immune system is known to adapt to external stimuli by the process of trained immunity and is thought to contribute to insulin resistance and the dysfunction of beta-cells. The investigation will analyze the programming state of innate immune cells in detail in the course of diabetes remission. In addition, islet hormone responses to challenge tests will be performed to assess their function in detail.
Interventions
BEHAVIORALweight loss by very low energy diet intake which may differ in protein or carbohydrate content
The anthropometric, endocrine and metabolic status is tested before, after 7 days and after 15 kg weight loss
Sponsors
Charite University, Berlin, Germany
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Obese people with type 2 diabetes with a duration of less then 4 years will be compared with people with type 2 diabetes for more than 8 years regarding their capability to achieve remission of type 2 diabetes in response to a weight loss of 15kg achived using very low calorie intake
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Type 2 diabetes diagnosed less than 4 or over 8 years, before study, * BMI \> 28 kg/m², * willingness to follow weight loss diet,
Exclusion criteria
* consuming disease, * intolerance for very low calorie formula diet, * known severe hepatic disease or liver cirrhosis, * type 1 diabetes, * severe disease of kidney or heart, * advanced diabetic retinopathy, * intake of glucocorticoids, * drug or alcohol abuse, * weight loss of \>5 kg in the last 3 month, * eating disorder
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Concentration of fasting blood glucose < 126 mg/deciliter | 3 month | Remission of type 2 diabetes defined by a concentration of a fasting blood glucose \< 126 mg/deciliter without diabetes medication |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Immune-metabolic profile and programing of innate immunity | before, after 7 days and after 3 month | Changes of cluster of differentiation 4/cluster of differentiation antigen 45 circulating immune cells in percent of CD4+ cells measured by flow cytometry in blood. Concentrations of TNFalpha in pg/ml, changes of Momocyte Chemoattractant Protein-1 in pg/ml. |
| Composition of the microbiome | before, after 7 days and after 3 month | Percent changes in firmicutes in stool, |
Countries
Germany
Outcome results
None listed